Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals

NCT04931017 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04931017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04931017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin for Chemoprevention of Lung Cancer in High-Risk Overweight or Obese Individuals
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 9, 2022
Completion date
June 30, 2027
Enrollment
50 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung carcinoma